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Abstract
A 32P-postlabeling assay has been developed for the simultaneous detection of the thymine glycol lesion and the
formamido remnant of pyrimidine bases in DNA exposed to reactive oxygen species (ROS). The formamido lesion is a
principal lesion produced in X-irradiated DNA oligomers when oxygen is available to mediate the damage process.
Production of the well-known thymine glycol lesion is less dependent on the concentration of oxygen. These two lesions have
the common property that they make the phosphoester bond 3P to the modified nucleoside resistant to hydrolysis by nuclease
P1. Our assay uses 32P-postlabeling to measure these lesions in the form of modified dimers obtained from DNA by nuclease
P1 digestion. Appropriate carriers and internal standards have been chemically synthesized to improve the reliability and
accuracy of the assay. The measurements were accomplished on 1-Wg samples of DNA. ß 1999 Elsevier Science B.V. All
rights reserved.
1. Introduction
Reactive oxygen species (ROS) have been impli-
cated in the etiologies of cancer [1], neurodegenera-
tive disease [2], and aging [3]. Ionizing radiation pro-
vides a convenient method for generating ROS.
When DNA oligomers are X-irradiated in aqueous
solution in the presence of oxygen, one of the major
products results from the breakdown of the thymine
and cytosine bases leaving a formamido remnant (I).
In oxygenated solution, the formamido lesion and
the more familiar 8-hydroxyguanine lesion are the
two monobasic lesions produced in largest abun-
dance [4^6]. In the absence of oxygen the yields of
both the formamido and 8-hydroxyguanine lesions
are drastically reduced. Formation of the formamido
lesion, (I), is initiated by addition of hydroxyl radical
to the unsaturated C5^C6 segment of a pyrimidine
base followed by the addition of oxygen to form a
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peroxyl radical. Reduction of the peroxyl radical
generates a hydroperoxide which is unstable and de-
grades to give the formamido remnant as a ¢nal
product [7]. A 32P-postlabeling assay has shown
that the G value for production of the formamido
lesion in calf thymus DNA X-irradiated in oxygen-
ated solutions is substantial (7.6 nmol per joule) [8].
In UVB-irradiated keratinocytes, the yields of the
formamido and the 8-hydroxyguanine lesions are
comparable [9]. Like the 8-hydroxyguanine, there ap-
pears to be a background level of the formamido
lesion in untreated cells.
Another well-known product of ROS activity is
the thymine glycol (5,6-dihydroxy-5,6-dihydrothy-
mine) lesion [10^14]. In X-irradiated DNA oligom-
ers, thymine glycol is produced much less abundantly
than either the formamido or the 8-hydroxyguanine
lesions when oxygen is present but more abundantly
than formamido or 8-hydroxyguanine when oxygen
is not available to mediate the damage process. The
thymine glycol modi¢cations that are of interest in
studies of ROS-induced DNA damage are the cis
isomers which are produced in DNA oligomers in
comparable yields. Our assay is designed to detect
the (5S,6R) isomer (II).
It seems likely that a more insightful measurement
of ROS-induced DNA damage would be an assay
that quantitated two lesions with di¡erent depend-
encies on oxygen for their formation. In this re-
port, we describe a highly selective and sensitive
method for simultaneously assaying of the form-
amido lesion (I) and the thymine glycol lesion (II)
in DNA.
Nuclease P1 is an endonuclease that is capable of
hydrolyzing undamaged DNA completely to the
mononucleotide level. The hydrolysis of phosphoest-
er bonds by nuclease P1 produces 5P-monophos-
phates. A characteristic of both the formamido lesion
and the thymine glycol lesions is that they inhibit
nuclease P1 hydrolysis of the phosphoester bond 3P
to the damaged nucleoside. The ability of nuclease
P1 to hydrolyze phosphoester bonds varies widely
even among the normal dinucleoside monophos-
phates [15,16]. Thus, the fastest turnover is for
d(ApT) and the slowest is for d(TpT) which on a
comparative scale are hydrolyzed at rates of 718
and 40 molecules per minute per molecule of enzyme,
respectively [16]. On the same scale the rate of hy-
drolysis for d(TpA) containing lesion II is 0.27. The
rates of hydrolysis for all of the dinucleoside mono-
phosphates d(TpN), when T is degraded to a form-
amido remnant, are too slow to measure under the
conditions used in this study. The relatively high re-
sistance of the phosphoester bonds 3P to nucleotides
bearing these lesions to hydrolysis by nuclease P1
means that both lesions can be obtained from a nu-
clease P1 (plus acid phosphatase) digest of DNA
predominantly in the form of modi¢ed dinucleoside
monophosphates. In this form, the lesions can be
5P end-labeled using polynucleotide kinase and
[Q-32P]ATP. Unmodi¢ed DNA makes up the bulk
of the digest and is in the form of nucleosides which
are not labeled by the kinase. Carriers have been
constructed which ensure unequivocal identi¢cation
of each lesion in the ¢nal step of the assay. The
carriers, in the form of dimers consisting of a 5P-
modi¢ed nucleoside and a normal 3P-nucleoside, are
practicable because the UV absorption of the normal
base makes location of the product of interest on a
thin-layer chromatography (TLC) plate, or in a high-
performance liquid chromatography (HPLC) elution
pro¢le, readily observable. Internal standards, in the
form of modi¢ed dinucleoside monophosphates,
were synthesized to monitor the e⁄ciencies of enzy-
matic steps used in the assay. Carriers and internal
standards are available commercially (Zeptogen
Corp., Getzville, NY).
2. Materials and methods
2.1. Synthesis of carriers and internal standards
The lesions are obtained from DNA in the forms
d(PFpA) and d(TGpA) where PF and TG refer to a
pyrimidine nucleoside having the base modi¢ed to
formamido, (I), and to thymidine having the base
modi¢ed to thymine glycol, (II), respectively. The
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modi¢ed dinucleoside monophosphates were pre-
pared starting with commercially available d(TpA)
(Sigma). The requisite carriers, d(pPFpA) and
d(pTGpA), are the top row of structures in
Fig. 1.
2.2. Synthesis of d(pPF pA)
In an ice-water bath, 60 Wl of a saturated solution
of bromine in water was added to 5 mg of d(TpA)
[17]. After 5 min, 60 Wl of pyridine were added and
Fig. 1. Carrier (top row), internal standards (middle row) and carriers for internal standards (bottom row) synthesized for use in as-
saying formamido and thymine glycol lesions.
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the mixture was placed in a 60‡ bath for 1 h. A
centrifugal concentrator was used to evaporate the
mixture to a syrup which was then dissolved in 500
Wl of a 2% NaIO4 solution. The reaction was allowed
to proceed overnight. The product of interest was
separated from a mixture of products by HPLC us-
ing a C18 reverse phase column eluted with a 0%^
10% linear gradient of acetonitrile/0.1 M ammonium
acetate bu¡er at pH 7.0. A typical yield of d(PFpA)
was 30%. Phosphorylation of the 5P-terminus was
Fig. 2. Assay for the detection of DNA lesions. The damaged DNA is digested enzymatically such that the lesion of interest is present
in the form of a modi¢ed dinucleoside monophosphate. This is accomplished using nuclease P1 in conjunction with prostatic acid
phosphatase. In the form of a modi¢ed dinucleoside monophosphate the lesion can be labeled using polynucleotide kinase and
[Q-32P]ATP. The bulk of the DNA is in the form of nucleosides and will not be labeled. The dimer carrier absorbs UV light and thus
can be detected on the TLC plate and during HPLC analysis, allowing the unequivocal location of the product of interest.
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accomplished enzymatically using T4 polynucleotide
kinase and non-radioactive ATP.
2.3. Synthesis of d(pTGpA)
To 5 mg d(TpA) in 1 ml of ice-cold 0.15 M
NH4Cl^NH4OH (pH 8.6) was added 1 ml of ice-
cold 0.04 M KMnO4 in the same bu¡er [18]. The
reaction was allowed to proceed at 0‡C for 2 min,
whereupon it was stopped by adding 150 Wl 10%
NaHSO3. Filtration through a 0.2-Wm membrane ¢l-
ter removed the precipitated MnO2. HPLC separa-
tion, as described above, showed the presence of two
glycol derivatives with a combined yield of 28%.
Phosphorylation was by T4 polynucleotide kinase
and ATP.
2.4. Synthesis of d(TpM)
Unmodi¢ed d(TpM), where M is N6-methyl-2P-de-
oxyadenosine (Glen Research), was synthesized by
the phosphotriester method [19]. Brie£y, d(TpM)
was synthesized from 5P-O-dimethoxytrityl-thymi-
dine-3P-(o-chlorophenyl) phosphate barium salt and
N6-methyl-2P-deoxyadenosine. A mixture containing
a slight excess of phosphorylated nucleotide was dis-
solved in anhydrous pyridine and treated with triiso-
propylbenzenesulfonylimidazolate in threefold excess
of the phosphorylated nucleotide. The desired 3PC5P
dimer was separated from other reaction products by
silica-gel chromatography (0%^3% methanol in
chloroform) and precipitated from hexane-diethyl-
ether (yield 56%). The base-labile protecting groups
were removed by treatment with a strong base (am-
monium hydroxide for 16 h at 50‡C). Acid-labile
protecting groups were removed by acid treatment
(acetic acid for 1 h, room temperature) to yield the
dinucleoside monophosphate. Puri¢cation was
achieved by chromatographic separation (HPLC) as
described above.
2.5. Synthesis and test of internal standards
Internal standards and carriers for the internal
standards for the formamido and thymine glycol le-
sions are shown in the second and third rows, respec-
tively, of Fig. 1. The syntheses of these materials was
carried out analogously to the syntheses described
above except for the obvious di¡erence that the start-
ing dinucleoside monophosphate was d(TpM) where
M is N6-methyl-2P-deoxyadenosine.
2.6. Preparation of samples
Denatured calf thymus DNA was X-irradiated ei-
ther 6 or 60 Gy in an aqueous solution sparged with
Fig. 3. The recovery of formamido lesion added to a DNA
sample, following hydrolysis and phosphorylation, as inferred
from the recovery of internal standard.
Fig. 4. The recovery of thymine glycol lesion added to a DNA
sample, following hydrolysis and phosphorylation, as inferred
from the recovery of internal standard.
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either oxygen or nitrogen. For samples sparged with
N2, the gas was ¢rst passed through an oxisorb col-
umn. Unirradiated calf thymus DNA, sparged with
oxygen and nitrogen and treated in the same manner
as irradiated samples, served as a control.
2.7. Postlabeling
One Wg of calf thymus DNA, together with 1 pmol
of each of the internal standards d(PFpM) and
d(TGpM), were dissolved in 88 mM sodium acetate
bu¡er (pH 5.0) containing 150 WM Zn Cl2, 4 Wg
nuclease P1 and 200 milliunits of prostatic acid phos-
phatase in a total volume of 10 Wl. The sample was
incubated at 37‡C for 1 h after which time the reac-
tion was stopped by adding 2.5 Wl 0.5 M Tris bu¡er.
The digestion products were then postlabeled as pre-
viously described [8,9]. Brie£y, the dinucleoside
monophosphates were phosphorylated using T4 poly-
nucleotide kinase and [Q-32P]ATP. After postlabeling,
the appropriate carriers were added, namely
d(pPFpA), d(pTGpA), d(pPFpM) and d(pTGpM),
and the bulk of the unincorporated radioactivity
was removed by solid phase extraction. The radio-
labeled products were separated by two-dimensional
TLC on 20U20 cm PEI cellulose TLC plates. Plates
were developed from bottom to top using 1.0 M
ammonium formate, pH 3.5. After washing, plates
were dried and then developed at 90‡C to the ¢rst
dimension using a borate bu¡er containing 6 g
Na2B4O7c10 H2O and 3 g H3BO3 in 70 ml distilled
water plus 25 ml ethylene glycol. Plates were dried
and placed in cassettes with X-ray ¢lm for 1 h at
room temperature. After autoradiography, spots
containing the lesions of interest and the internal
references were clearly identi¢ed by the UV absorb-
ance of the carriers. These spots were cut from the
TLC plate and the radioactivity eluted from the plate
using NaCl. Further resolution of the lesions was
achieved by HPLC in which the UV absorptions of
the carriers served to sharply de¢ne the radiolabeled
dinucleoside monophosphates containing the lesions
of interest. The radioactivity eluting with each carrier
was quantitated using a continuous £ow radioactiv-
ity detector (IN/US Systems).
3. Results
An overall scheme of the assay for the detection of
ROS-induced DNA damages is shown in Fig. 2. The
Fig. 5. Representative autoradiograms of 32P-postlabeling analy-
sis of DNA adducts in calf thymus DNA. (A) control (O2
only); (B) X-irradiated (60 Gy in O2). Dashed circles indicate
the location of the UV-visible carriers for pTGpM (spot 1),
pPFpM (spot 2), pTGpA (spot 3), and pPFpA (spot 4). Spots 5
and 6 in panel B are unknown adducts that appeared to be re-
lated to X-irradiation, and the arrow indicates a radioactive
product associated with [Q-32P]ATP. The origin (lower left hand
corner) has been cropped from the original autoradiogram.
Chromatography was from the bottom to top (D1) and from
left to right (D2) using the solvents described in Section 2.
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assay involves two enzymatic processes, namely the
initial nuclease P1 (plus acid phosphatase) hydrolysis
of DNA and the subsequent phosphorylation of the
hydrolysate using T4 polynucleotide kinase and
[Q-32P]ATP. The purpose of the internal standards
added to the DNA sample before hydrolysis in Fig.
2 is to provide a quantitative measure of the e⁄cien-
cies of the enzymatic processes. One pmol of internal
standard in the form d(N*pM), where N* is the nu-
cleoside bearing the lesion and M is N6-methyl-2P-
deoxyadenosine, is added to the DNA sample before
the digestion is started. In the hydrolysis step, the
lesions of interest persist in the hydrolysate primarily
in the form of modi¢ed dinucleoside monophos-
phates due to the resistance, imparted by the lesions,
to nuclease P1 as discussed above. However, the in-
hibition is not absolute and some lesions may be lost
to measurement due to hydrolysis of modi¢ed dinu-
cleoside monophosphates. Also, the phosphorylation
step in 32P-postlabeling may not be complete. Quan-
titation is usually accomplished in 32P-postlabeling
by carefully maintaining conditions so that the per-
centage of phosphorylation remains the same as
measured in control samples. We sought to monitor
the overall e¡ect of both enzymatic steps on quanti-
tation by adding internal standards to each DNA
sample. The rationale for the use of internal stand-
ards is based on observations that both the hydrol-
ysis and the phosphorylation of dinucleoside mono-
phosphates depend primarily on the nature of the 5P-
nucleosides. The incorporation of an internal stand-
ard in every sample has greatly improved quantita-
tion of the lesions.
In order to experimentally verify that the internal
standards serve the intended purpose, samples were
made up containing 1 Wg of calf thymus DNA,
1 pmol each of d(PFpM) and d(TGpM), and various
amounts of d(PFpA) and d(TGpA). The samples were
hydrolyzed with nuclease P1 and prostatic acid phos-
phatase and were postlabeled as described in Section
2. Samples together with carriers were spotted on a
PEI-cellulose TLC plate and subjected to two-dimen-
sional chromatography. Radioactive spots were lo-
cated by autoradiography and carriers were located
Fig. 6. Representative HPLC traces of spots eluted from TLC plates used for 32P-postlabeling analysis of DNA adducts in calf thy-
mus DNA. (A) Spots 2 and 4 containing dimers with the formamido lesion (see Fig. 1); (B) Spots 1 and 3 containing dimers with the
glycol lesion (see Fig. 1). Top tracings are of UV absorbance at 254 nm and bottom tracings are of radioactivity associated with the
eluted spots. The samples presented are from calf thymus DNA exposed to 60 Gy X-irradiation in O2.
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by their UV absorbance. Spots corresponding to the
UV carriers were cut from the plate and the radio-
activity eluted. The eluted material was further re-
solved by HPLC [20] and the radioactivity in the
lesions and internal standards determined using an
online radioactivity detector (IN/US Systems). The
observed amount of lesion was calculated from a
simple proportion: amount of lesion is to the meas-
ured DPM for the lesion as the added amount of
internal standard is to the measured DPM for the
internal standard. The results are shown in Fig. 3
for the formamido lesion and in Fig. 4 for the thy-
mine glycol lesion. For both lesions, a linear corre-
lation was observed between the amount added and
the amount measured by the postlabeling method. As
little as 3 fmol/Wg PFpA and 30 fmol/Wg of TGpA
could be detected reproducibly and quantitatively.
The same linearity was observed when the amount
of the DNA sample was increased to 5 Wg.
Measurements of the formamido and thymine gly-
col lesions using the postlabeling procedure were
made on calf thymus DNA X-irradiated in an oxy-
genated environment. Fig. 5 shows a typical spot
distribution on a TLC plate. Spots denoted by car-
riers were cut from the plate and the radioactivity
eluted. The eluted material was run on HPLC. Typ-
ical elution pro¢les are shown in Fig. 6. The results
of the assay applied to calf thymus DNA exposed to
X-irradiation in the presence of oxygen are given in
Table 1.
With oxygen present, the yield of formamido le-
sion at 60 Gy was more than 100 times the back-
ground level of the lesion in unirradiated DNA. A
more modest increase in the yield of the thymine
glycol lesions was observed. This result reinforces
previous impressions gained at the oligomer level
that the formamido lesion is a principal lesion, if
not the principal DNA lesion resulting from ROS
exposure. This result is particularly interesting be-
cause the thymine glycol lesion is a well-established
ROS product whereas the formamido lesion is gen-
erally overlooked in the literature of ROS-induced
DNA damage.
Measurements, using the postlabeling procedure,
were also made of the formamido and thymine glycol
lesions on calf thymus DNA X-irradiated in an an-
oxic environment (Table 2). The thymine glycol le-
sion increased as a function of dose in about the
same amount as in the presence of oxygen. The yield
of the formamido lesion, on the other hand, was
drastically reduced.
4. Discussion
We have developed a sensitive 32P-postlabeling as-
say for simultaneous measurements of two ROS-in-
duced DNA lesions namely the formamido remnant
(I) and thymine glycol (II). Simultaneous measure-
ment of the formamido and thymine glycol lesions
in studies of ROS-induced DNA damage proves to
be more insightful than measurement of a single le-
sion in view of the fact that each lesion is in£uenced
di¡erently by the oxygen content in the environment
of the DNA. The case is made for simultaneous
measurement of both lesions in DNA in order to
better assess the e¡ects of ROS activity. Our results
were obtained by isolating the formamido and thy-
mine glycol lesions in the form d(N*pA) where N*
represents the modi¢ed nucleoside. This approach of
detecting lesions that inhibit nuclease P1 at the dimer
level was used by Randerath et al. [21] to assay for
bulky lesions in DNA by 32P-postlabeling. The le-
sions were detected by 32P-postlabeling of the modi-
Table 1
Yields of the formamido and thymine glycol lesions in calf thy-
mus DNA exposed to X-irradiation in the presence of oxygen
Dose d(PFpA)a d(TGpA)a
0 Gy (O2) 34.0 (11.5) 10.6 (2.7)
6 Gy (O2) 466 (176) 65.4 (10.0)
60 Gy (O2) 3315 (279) 586 (120)
aYield in fmol/Wg is the mean of 3^4 replicate samples. Stand-
ard deviations are in parentheses.
Table 2
Yields of formamido and thymine glycol lesions in calf thymus
DNA exposed to X-irradiation in the absence of oxygen
Dose d(PFpA)a d(TGpA)a
0 Gy (N2) 45.2 (18.3) 20.1 (7.8)
6 Gy (N2) 63.4 (28.3) 38.3 (16.2)
60 Gy (N2) 385 (155) 378 (152)
aYield in fmol/Wg is the mean of 3^4 replicate samples. Stand-
ard deviations are in parentheses.
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¢ed dinucleoside monophosphates. Carriers of the
form d(pN*pA) were synthesized for unequivocal
identi¢cation of the lesions in the ¢nal step of the
assay. Internal standards of the form d(N*pM),
where M stands for N6-methyl-2P-deoxyadenosine,
were synthesized to monitor recovery of lesions by
the assay. The internal standards are collectively
added to the DNA sample at the outset of the pro-
cedure; similarly, the carriers are collectively added
to the sample following postlabeling. The internal
standards and carriers are chemically synthesized in
milligram quantities which therefore su⁄ce for many
measurements. In the presence of oxygen, the yield of
thymine glycol lesion was much less than the yield of
formamido lesion. In the absence of oxygen, the
yields of the thymine glycol lesion and formamido
lesions were comparable. Whereas the yield of form-
amido lesion was much enhanced in an oxygenated
environment, the yield of the thymine glycol lesion
was relatively independent of oxygen. These trends
re£ect results previously observed in irradiated short
sequence DNA oligomers [5,6].
The main goal of this investigation was to devise a
method of measuring ROS-induced DNA damage
that will take into account the e¡ect of oxygen. Oxy-
gen is likely to be the main mediator of ROS-induced
DNA damage in biological systems. It seems advis-
able, therefore, to monitor ROS-induced damage us-
ing an assay for that can re£ect the presence or ab-
sence of oxygen e¡ects. The sensitivity of the 32P-
postlabeling method for detecting DNA damage is
probably unsurpassed. A 1-Wg sample of DNA is
su⁄cient for the analysis. The main drawbacks of
postlabeling, namely ambiguities in product identi¢-
cation and di⁄culties in quantitation, have been
overcome in our application of the method by the
use of carriers and internal standards. The formami-
do lesion appears to be a particularly judicious
choice for monitoring ROS-induced DNA damage.
The lesion is abundantly produced in the presence of
oxygen, yet the possible mechanisms for its produc-
tion are more limited than for the 8-hydroxyguanine
lesion which is often taken as an indicator of oxida-
tive stress. It should be noted that the formamido
lesion is not among the lesions that can be monitored
by the GC-MS method of assaying DNA damage
pioneered by Dizdaroglu and his colleagues [22].
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